The Role of Platelets in Essential Hypertension
- 1 January 1995
- journal article
- review article
- Published by Taylor & Francis in Blood Pressure
- Vol. 4 (4) , 199-214
- https://doi.org/10.3109/08037059509077596
Abstract
Recent research is helping us understand the complex interactions that occur between platelets and their environment. The several intracellular events that occur during platelet activation are being identified as are their effects on other platelets, the endothelium and coagulation factors. Heightened platelet activation is seen early in essential hypertension and probably plays an important role in the initiation and progression of atherosclerosis and the disorders associated with it. This review identifies some of the changes in platelet structure and function in essential hypertension and their role in the pathogenesis of hypertensive vascular disease.Keywords
This publication has 163 references indexed in Scilit:
- Concurrent Morning Increase in Platelet Aggregability and the Risk of Myocardial Infarction and Sudden Cardiac DeathNew England Journal of Medicine, 1987
- Effects of a Circulating Factor in Patients with Essential Hypertension on Intracellular Free Calcium in Normal PlateletsNew England Journal of Medicine, 1987
- Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cellsBiochemical and Biophysical Research Communications, 1985
- Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjectsLife Sciences, 1984
- Correlation of Platelet Calcium with Blood PressureNew England Journal of Medicine, 1984
- Cerebral and aortic atherosclerosis in Hisayama, JapanAtherosclerosis, 1980
- Effect of Cholesterol on Production of Thromboxane B2by Platelets in VitroNew England Journal of Medicine, 1980
- The efflux rate of norepinephrine from platelets and its relation to blood pressureLife Sciences, 1979
- Alpha-adrenergic receptor subtypes: Quantitative assessment by ligand bindingLife Sciences, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978